A phase II study of a temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424. Article

Fisher, Barbara Jean, Lui, Jeff, Macdonald, David R et al. (2013). A phase II study of a temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas: Preliminary results of RTOG 0424. . JOURNAL OF CLINICAL ONCOLOGY, 31(15_suppl), 2008-2008. 10.1200/jco.2013.31.15_suppl.2008

cited authors

  • Fisher, Barbara Jean; Lui, Jeff; Macdonald, David R; Lesser, Glenn Jay; Coons, Stephen; Brachman, David; Ryu, Samuel; Werner-Wasik, Maria; Bahary, Jean-Paul; Hu, Chen; Mehta, Minesh P

authors

publication date

  • May 20, 2013

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.1 Pharmaceuticals
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Cardiovascular
  • Clinical Research
  • Neurosciences
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 2008

end page

  • 2008

volume

  • 31

issue

  • 15_suppl